Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Deciphering the PTM codes of the tumor suppressor p53
Jia Wen, Donglai Wang
Journal of Molecular Cell Biology (2021) Vol. 13, Iss. 11, pp. 774-785
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

The ARTS of p53-dependent mitochondrial apoptosis
Qian Hao, Jiaxiang Chen, Hua Lu, et al.
Journal of Molecular Cell Biology (2022) Vol. 14, Iss. 10
Open Access | Times Cited: 73
Post-Translational Modifications of Proteins Orchestrate All Hallmarks of Cancer
Pathea Bruno, Aneeta Arshad, Maria-Raluca Gogu, et al.
Life (2025) Vol. 15, Iss. 1, pp. 126-126
Open Access | Times Cited: 2
p53 Modulation of Autophagy Signaling in Cancer Therapies: Perspectives Mechanism and Therapeutic Targets
Md. Ataur Rahman, Moon Nyeo Park, MD. Hasanur Rahman, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 57
Interplay between posttranslational modifications and liquid‒liquid phase separation in tumors
Xiaojun Yan, Meng Zhang, Donglai Wang
Cancer Letters (2024) Vol. 584, pp. 216614-216614
Closed Access | Times Cited: 11
Chemical proteomics approaches for protein post-translational modification studies
Nan Zhang, Jinghua Wu, Qingfei Zheng
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (2024) Vol. 1872, Iss. 4, pp. 141017-141017
Open Access | Times Cited: 10
At a Crossroads to Cancer: How p53-Induced Cell Fate Decisions Secure Genome Integrity
Dario Rizzotto, Lukas Englmaier, Andreas Villunger
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10883-10883
Open Access | Times Cited: 52
Deciphering the acetylation code of p53 in transcription regulation and tumor suppression
Zhangchuan Xia, Ning Kon, Alyssa P. Gu, et al.
Oncogene (2022) Vol. 41, Iss. 22, pp. 3039-3050
Open Access | Times Cited: 31
Enhancing cancer treatment via “Zn2+ interference” with Zn-based nanomaterials
Yandong Wang, Fucheng Gao, Zhao Li, et al.
Coordination Chemistry Reviews (2023) Vol. 500, pp. 215535-215535
Closed Access | Times Cited: 21
The p53 protein – not only the guardian of the genome
Marek Rusin
Postępy Biochemii (2024) Vol. 70, Iss. 1, pp. 71-87
Open Access | Times Cited: 5
Inhibitors of the tyrosine kinases FMS-like tyrosine kinase-3 and WEE1 induce apoptosis and DNA damage synergistically in acute myeloid leukemia cells
Christoph Hieber, Al‐Hassan M. Mustafa, Sarah Neuroth, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117076-117076
Open Access | Times Cited: 4
Lactylation affects p53 Nuclear Translocation to Promote Colorectal Cancer Progression
Jie Ma, Yao Dai, Wenxin Da, et al.
Research Square (Research Square) (2025)
Closed Access
Versatile roles of disordered transcription factor effector domains in transcriptional regulation
Rhea R. Datta, Dilan Akdogan, Elif B. Tezcan, et al.
FEBS Journal (2025)
Open Access
The R337C mutation in the p53 oligomerization domain affects the regulatory domain and its ability to bind response elements: Evidence based on structural and biophysical studies.
Alankrita Singh, Lakshay Malhotra, Abhay Mishra, et al.
Archives of Biochemistry and Biophysics (2025), pp. 110381-110381
Closed Access
RSK2 and its binding partners: an emerging signaling node in cancers
Hye Suk Lee, Sung-Jun Cho, Han Chang Kang, et al.
Archives of Pharmacal Research (2025)
Closed Access
Genetic insight into lung neuroendocrine tumors: Notch and Wnt signaling pathways as potential targets
Giulia Pecora, Camilla Mancini, Rossella Mazzilli, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
NOBILETIN AMELIORATES HEATSTROKE-INDUCED ACUTE LUNG INJURY BY INHIBITING FERROPTOSIS VIA P53/SLC7A11 PATHWAY
Hui Chen, Weidang Xie, Zanling Peng, et al.
Shock (2023)
Open Access | Times Cited: 9
Protein of a thousand faces: The tumor-suppressive and oncogenic responses of p53
Mayra A. Marques, Guilherme C. de Andrade, Jerson L. Silva, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 12
Pancreatic β‑cell apoptosis in type 2 diabetes is related to post‑translational modifications of p53 (Review)
Luis Antonio Flores-López, Sergio Enríquez‐Flores, De Ji, et al.
Molecular Medicine Reports (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 2
RNA Modifications Meet Tumors
Zhiyuan Yang, Siyu Zhang, Tian Xia, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 3223-3243
Open Access | Times Cited: 11
The chameleonic behavior of p53 in health and disease: the transition from a client to an aberrant condensate scaffold in cancer
Mayra A. Marques, Guilherme A. P. de Oliveira, Jerson L. Silva
Essays in Biochemistry (2022) Vol. 66, Iss. 7, pp. 1023-1033
Closed Access | Times Cited: 10
The next decade of SET: from an oncoprotein to beyond
Han Yao, Meng Zhang, Donglai Wang
Journal of Molecular Cell Biology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 6
A review on cullin neddylation and strategies to identify its inhibitors for cancer therapy
Iqra Bano, Moolchand Malhi, Min Zhao, et al.
3 Biotech (2022) Vol. 12, Iss. 4
Open Access | Times Cited: 8
Mechanisms of carcinogenic activity triggered by lysine-specific demethylase 1A
Chao Yang, Dan Li, Shaohong Zang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Cellular and epigenetic perspective of protein stability and its implications in the biological system
Nisha Manav, Bimal Prasad Jit, Babita Kataria, et al.
Epigenomics (2024) Vol. 16, Iss. 11-12, pp. 879-900
Closed Access | Times Cited: 1
UBE1C is upregulated and promotes neddylation of p53 in lung cancer
Hsun Liu, Yung‐Hsin Shih, Wen‐Lun Wang, et al.
The FASEB Journal (2023) Vol. 37, Iss. 10
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top